NCT05977426 is a NA clinical trial of Reiki in Therapeutic Touch, sponsored by Inonu University.

Who is sponsoring NCT05977426?

NCT05977426 is sponsored by Inonu University.

What drugs are being tested in NCT05977426?

Interventions in NCT05977426: Reiki.

What condition does NCT05977426 study?

NCT05977426 studies Therapeutic Touch, Menopausal Symptoms.

Is NCT05977426 still recruiting?

NCT05977426 is currently completed. Last updated 4 August 2023.

Last reviewed 2023-08-04 · How we verify

NCT05977426

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effects of Reiki on Menopausal Symptoms and Depression Levels

Completed NA Last updated 4 August 2023

What this trial tests

NA trial testing Reiki in Therapeutic Touch in 82 participants. Completed in 23 July 2023.

Timeline

1 May 2023

Primary endpoint
1 June 2023

23 July 2023

Quick facts

Lead sponsor	Inonu University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	single
Primary purpose	supportive care
Enrollment	82
Start date	1 May 2023
Primary completion	1 June 2023
Estimated completion	23 July 2023
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Reiki

Conditions studied

Therapeutic Touch — all drugs for Therapeutic Touch →
Menopausal Symptoms — all drugs for Menopausal Symptoms →

Sponsor

Inonu University

Who can join

Adults 45 to 55, female only, with Therapeutic Touch or Menopausal Symptoms. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Objective: This study was conducted to determine the effects of Reiki applied to women in the postmenopausal period on menopausal symptoms and depression levels. Methodology:This randomized controlled study was conducted with postmenopausal women registered in a family health center in eastern Türkiye. The sample of the study consisted of 82 women, 41 in the Reiki group and 41 in the control group. While four sessions of Reiki were applied to the women in the Reiki group, once a week for 4 weeks, no intervention was applied to the control group. Menopause Rating Scale (MRS) and Beck Depression Inventory (BDI) were used to collect data.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Reiki for decrease postmenopausal symptoms and depression: a randomized clinical trial.
Baransel ES, Uçar T. · · 2025 · cited 1× · PMID 40802410 · DOI 10.1590/1806-9282.20250076

Verify or expand the search:

Other trials of Reiki

Trials testing the same drug.

NCT07193784 — Effect of Reiki Applied After Coronary Angiography on Pain and Comfort Level · NA · completed
NCT07254520 — The Effects of Reiki Therapy in Infants With Colic · NA · recruiting
NCT07083856 — Effects of Reiki and Self-Acupressure Applications · NA · recruiting
NCT06526949 — The Effect of Reiki on Pain, Anxiety and Haemodynamic Parameters in Patients Receiving Mechanical Ventilator Support · NA · completed
NCT06354049 — Reiki Therapy to Improve Key Symptoms in Integrative Oncology Clinic (REIKI) · NA · completed

Other Inonu University trials

Trials by the same sponsor.

NCT06553807 — Genital Self İmage and Satisfaction With Genital Appearance · NA · not yet recruiting
NCT07480122 — Motor Imaging, Neglect, and Upper Extremity Function in Stroke · not yet recruiting
NCT07463326 — The Efficacy of Transcutaneous Tibial Nerve Stimulation in Women With Idiopathic Overactive Bladder · NA · enrolling by invitation
NCT07510737 — The Effect of Cross Training on Clinical and Functional Outcomes in Frozen Shoulder Rehabilitation · not yet recruiting
NCT07530211 — The Effect of Systemic Factors on Peri-implant Health Status and Clinical Indices · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05977426 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Inonu University
Last refreshed: 4 August 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05977426.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing